Hard to Treat Diseases Inc.
Hard to Treat Diseases Inc. (HTDS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HTDS · as of Jun 9, 2026
Key Statistics
Explore Hard to Treat Diseases Inc. Data
htds stock data · financialsCompetitors & Peers
htds competitorsHTDS
EHOS
GBLX
GSTC
IMEXF
IRBSStock Performance
Full HistoryAbout Hard to Treat Diseases Inc.
Hard to Treat Diseases Inc. (HTDS), founded in 2009 and headquartered in Shenzhen, China, is a pharmaceutical firm engaged in the development, manufacturing, and global export of biopharmaceutical pro…
what is hard to treat diseases inc. · htds stock overview · hard to treat diseases inc. company profile · who is hard to treat diseases inc. ceo · htds OTC · hard to treat diseases inc. headquarters · hard to treat diseases inc. business segments
About Stock Overview & Key Data
Hard to Treat Diseases Inc. (HTDS) is a Healthcare company in the Biotechnology industry, listed on OTC since Sep 25, 1998. As of the latest trading session, HTDS stock price is $0.00, with a market capitalization of $109,647. The stock has returned +0.00% over the past 12 months and +1900.00% year-to-date.
Frequently Asked Questions
As of the latest trading session, Hard to Treat Diseases Inc. (HTDS) stock price is $0.00. The stock is traded on OTC under the ticker symbol HTDS. The 52-week range is $0.00 – $0.00.